Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.36 AUD | +7.46% | +7.46% | +75.61% |
May. 01 | Dimerix Secures Pediatric Plan Approval in the UK for Kidney Disease Medication | MT |
Apr. 22 | Dimerix Posts AU$35.2 Million Cash, AU$3.3 Million Operating Cash Outflows for March Quarter | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+75.61% | 120M | |
+24.69% | 48.09B | |
+46.90% | 40.62B | |
-3.29% | 40.43B | |
-6.20% | 28.36B | |
+9.30% | 24.89B | |
-20.58% | 19.01B | |
+28.41% | 12.09B | |
+0.45% | 11.88B | |
-1.37% | 11.8B |
- Stock Market
- Equities
- DXB Stock
- News Dimerix Limited
- Dimerix Secures Regulatory Nod to Conduct Kidney Disease Drug Trial in Malaysia